JP2007513076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513076A5 JP2007513076A5 JP2006538730A JP2006538730A JP2007513076A5 JP 2007513076 A5 JP2007513076 A5 JP 2007513076A5 JP 2006538730 A JP2006538730 A JP 2006538730A JP 2006538730 A JP2006538730 A JP 2006538730A JP 2007513076 A5 JP2007513076 A5 JP 2007513076A5
- Authority
- JP
- Japan
- Prior art keywords
- zero
- carbon atoms
- alkyl
- hydrogen
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10353202A DE10353202A1 (de) | 2003-11-13 | 2003-11-13 | Pentafluorsulfuranyl-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| PCT/EP2004/012393 WO2005047239A1 (de) | 2003-11-13 | 2004-11-03 | Pentafluorsulfanyl-benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007513076A JP2007513076A (ja) | 2007-05-24 |
| JP2007513076A5 true JP2007513076A5 (https=) | 2007-12-13 |
| JP4528304B2 JP4528304B2 (ja) | 2010-08-18 |
Family
ID=34585094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538730A Expired - Fee Related JP4528304B2 (ja) | 2003-11-13 | 2004-11-03 | ペンタフルオロスルファニルベンゾイルグアニジン、その製造方法、医薬又は診断薬としてのその使用及びそれらを含有する医薬 |
Country Status (38)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7317124B2 (en) | 2003-11-13 | 2008-01-08 | Sanofi-Aventis Deutschland Gmbh | Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates |
| SI2242740T1 (sl) | 2008-02-05 | 2013-03-29 | Sanofi | SF5-derivati kot PAR1 inhibitorji, njihova priprava in uporaba kot zdravila |
| EP2661434A4 (en) * | 2011-01-06 | 2014-07-09 | Beta Pharma Canada Inc | NEW UREAS FOR THE TREATMENT AND PREVENTION OF CANCER |
| CN106414402A (zh) | 2013-11-01 | 2017-02-15 | 宇部兴产株式会社 | 丙烯酰(氧基或氨基)五氟硫烷基苯化合物、其药学可接受的盐及其前药 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59305042D1 (de) * | 1992-09-22 | 1997-02-20 | Hoechst Ag | Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika |
| DE4417004A1 (de) * | 1994-05-13 | 1995-11-16 | Hoechst Ag | Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19517848A1 (de) * | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorhaltige Benzoylguanidine |
| DE19526381A1 (de) * | 1995-07-19 | 1997-01-23 | Hoechst Ag | 4-Fluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19713427A1 (de) * | 1997-04-01 | 1998-10-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19950898A1 (de) * | 1999-10-22 | 2001-04-26 | Aventis Pharma Gmbh | Heterocyclisch substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10222192A1 (de) * | 2002-05-18 | 2003-11-27 | Aventis Pharma Gmbh | Pentafluorsulfuranyl-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10338554A1 (de) * | 2003-08-22 | 2005-03-31 | Aventis Pharma Deutschland Gmbh | Pentafluorosulfanylphenyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
2003
- 2003-11-03 OA OA1200600153A patent/OA13285A/en unknown
- 2003-11-13 DE DE10353202A patent/DE10353202A1/de not_active Withdrawn
-
2004
- 2004-10-06 JO JO2004140A patent/JO2466B1/en active
- 2004-10-27 GT GT200400217A patent/GT200400217A/es unknown
- 2004-11-03 UA UAA200606449A patent/UA84307C2/ru unknown
- 2004-11-03 WO PCT/EP2004/012393 patent/WO2005047239A1/de not_active Ceased
- 2004-11-03 DE DE502004004460T patent/DE502004004460D1/de not_active Expired - Lifetime
- 2004-11-03 JP JP2006538730A patent/JP4528304B2/ja not_active Expired - Fee Related
- 2004-11-03 RU RU2006120448/04A patent/RU2380358C2/ru not_active IP Right Cessation
- 2004-11-03 PL PL04797535T patent/PL1685096T3/pl unknown
- 2004-11-03 BR BRPI0416487-3A patent/BRPI0416487A/pt not_active IP Right Cessation
- 2004-11-03 AU AU2004288758A patent/AU2004288758B2/en not_active Ceased
- 2004-11-03 HR HR20070364T patent/HRP20070364T3/xx unknown
- 2004-11-03 ES ES04797535T patent/ES2287788T3/es not_active Expired - Lifetime
- 2004-11-03 DK DK04797535T patent/DK1685096T3/da active
- 2004-11-03 NZ NZ547172A patent/NZ547172A/en not_active IP Right Cessation
- 2004-11-03 CN CNB200480033483XA patent/CN100445265C/zh not_active Expired - Fee Related
- 2004-11-03 CA CA2551057A patent/CA2551057C/en not_active Expired - Fee Related
- 2004-11-03 EP EP04797535A patent/EP1685096B1/de not_active Expired - Lifetime
- 2004-11-03 RS RSP-2007/0368A patent/RS50520B/sr unknown
- 2004-11-03 PT PT04797535T patent/PT1685096E/pt unknown
- 2004-11-03 AT AT04797535T patent/ATE368029T1/de active
- 2004-11-10 DO DO2004001028A patent/DOP2004001028A/es unknown
- 2004-11-11 AR ARP040104156A patent/AR046620A1/es not_active Application Discontinuation
- 2004-11-11 HN HN2004000474A patent/HN2004000474A/es unknown
- 2004-11-11 TW TW093134390A patent/TWI334411B/zh not_active IP Right Cessation
- 2004-11-12 MY MYPI20044737A patent/MY144211A/en unknown
- 2004-11-12 PE PE2004001110A patent/PE20051034A1/es not_active Application Discontinuation
- 2004-11-12 UY UY28616A patent/UY28616A1/es not_active Application Discontinuation
-
2006
- 2006-03-29 ZA ZA200602579A patent/ZA200602579B/xx unknown
- 2006-03-31 CR CR8321A patent/CR8321A/es unknown
- 2006-04-21 TN TNP2006000116A patent/TNSN06116A1/en unknown
- 2006-04-26 IL IL175237A patent/IL175237A/en not_active IP Right Cessation
- 2006-05-11 KR KR1020067009186A patent/KR101262065B1/ko not_active Expired - Fee Related
- 2006-05-11 EC EC2006006563A patent/ECSP066563A/es unknown
- 2006-05-12 NI NI200600112A patent/NI200600112A/es unknown
- 2006-05-12 MA MA29028A patent/MA28161A1/fr unknown
- 2006-06-08 NO NO20062635A patent/NO20062635L/no unknown
-
2007
- 2007-09-14 CY CY20071101190T patent/CY1106868T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6227707B2 (ja) | Ｍｃｌ‐１を調節する小分子、並びに細胞死、細胞分裂、細胞分化を調節する方法、及び疾患を治療する方法。 | |
| ES2673160T5 (es) | Moduladores selectivos del receptor de la esfingosina 1 fosfato y métodos de síntesis quiral | |
| TWI457337B (zh) | 呋呫基苯并咪唑 | |
| JP2005529182A5 (https=) | ||
| JP2013526494A5 (https=) | ||
| JP2015531773A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JPH02157258A (ja) | トロンボキサンａ↓２拮抗作用を有する化合物 | |
| JP2007512283A5 (https=) | ||
| JP2014502979A5 (https=) | ||
| JPWO2020123827A5 (https=) | ||
| CN1479734A (zh) | 具有钾通道阻断作用的芳基化呋喃和噻吩甲酰胺 | |
| PT1708991E (pt) | Derivados de sulfonamida para o tratamento de doenças | |
| JP2005526138A5 (https=) | ||
| ES2548258T3 (es) | Compuestos de oxadiazol sustituidos y su uso como agonistas de S1P1 | |
| JP2004307440A (ja) | ２−アミノ‐１，３‐プロパンジオール誘導体とその付加塩 | |
| RU2010113358A (ru) | Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов | |
| JPWO2023195529A5 (https=) | ||
| JP2021533206A5 (https=) | ||
| JP2008519783A5 (https=) | ||
| CA2626402A1 (en) | Potassium channel inhibitors | |
| RU2008118201A (ru) | Антагонист рецептора s1p3 | |
| JPH1081664A5 (https=) | ||
| JP2007513076A5 (https=) | ||
| JP6228667B2 (ja) | 新規な抗真菌性オキソジヒドロピリジンカルボヒドラジド誘導体 | |
| WO1998043943A1 (fr) | Derives de 2-phenoxyaniline |